Terho Heikkinen
Professor of Paediatrics, MD, PhD
teheikki@utu.fi ORCID identifier: https://orcid.org/0000-0001-6504-0116 |
Paediatric infectious diseases; respiratory infections; respiratory viruses; vaccinations; influenza; respiratory syncytial virus; otitis media
Respiratory infections in children; RESCEU (EU/IMI-funded project 2017-2021); INFORM study
Professor Terho Heikkinen graduated from the Medical School at the
University of Turku in 1984, where he also specialized in Paediatrics and Paediatric
Infectious Diseases. He defended his thesis on Development and prevention of acute
otitis media in children in 1994. Having received the European Society for
Paediatric Infectious Diseases Fellowship Award, he worked in 1996-1998 as
a post-doc Research Fellow at the University of Texas Medical Branch at
Galveston, USA. Subsequently, he worked as a Senior Clinical Researcher and
Clinical Lecturer at the Department of Paediatrics, University of Turku. Since
2016, he has been Professor of Paediatrics at
the Faculty of Medicine, University of Turku.
During the years, Terho Heikkinen has served as the chairman or a board member
of several international and domestic societies in the field of paediatric
infectious diseases, including the President of the World Society for
Pediatric Infectious Diseases. He is currently a board member of the European Scientific
Working Group on Influenza (ESWI), a scientific advisory board and executive committee member of the global Respiratory Syncytial Virus Network (ReSViNET), and the chairman of the Nordic Research Network for Paediatric Infectious Diseases (NORDPID).
Terho Heikkinen´s major research interest lies in respiratory infections,
especially those caused by influenza or respiratory syncytial viruses. In year 2000, he founded his own research group and initiated a long-term research project on respiratory virus infections in children,
including the etiology, epidemiology, diagnosis, treatment, prevention, and
overall societal impact of these infections and their complications.
Terho Heikkinen has been
actively involved in international research collaboration. In 2014, he was a founding member of ReSViNET, a global respiratory syncytial virus research network.
He is also a principal investigator in RESCEU (Respiratory syncytial virus
consortium in Europe) that in 2017 received 5-year EU/IMI funding for research
on the burden of respiratory syncytial virus infections in Europe. He was also a founding member of the Nordic Research Network for Paediatric Infectious Diseases (NORDPID) that was established in 2018.
Since 1999, Terho Heikkinen has worked as a full-time
teacher of paediatrics at the Department of Paediatrics, University of Turku. He
is also responsible for the organization of the biannual International Course
of Paediatrics & Adolescent Medicine for international Erasmus students. He
has given 188 invited lectures at various international and domestic academic
meetings.
- Comparison of Hospitalization Rates and Clinical Features Between Boys and Girls With Respiratory Syncytial Virus Infection (2026)
- Influenza and Other Respiratory Viruses
(A1 Refereed original research article in a scientific journal) - Antibiotic use attributable to RSV infections during infancy—an international prospective birth cohort study (2025)
- Journal of Antimicrobial Chemotherapy
(A1 Refereed original research article in a scientific journal) - Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic (2025)
- Nature Communications
(A1 Refereed original research article in a scientific journal) - Estimation of respiratory syncytial virus-associated hospital admissions in five European countries: a modelling study (2025)
- Lancet regional health - Europe
(A1 Refereed original research article in a scientific journal) - Hospitalisation trends of respiratory syncytial virus (RSV) infection in adults, six European countries, before and during COVID-19, 2016 to 2023 (2025)
- Eurosurveillance
(A1 Refereed original research article in a scientific journal) - Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre-and post-COVID-19 pandemic (2025)
- International Journal of Infectious Diseases
(A1 Refereed original research article in a scientific journal) - Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants (2025)
- Nature Communications
(A1 Refereed original research article in a scientific journal) - Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce (2025)
- Open Forum Infectious Diseases
(A2 Refereed review article in a scientific journal ) - Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children (2025)
- Expert Review of Anti-infective Therapy
(A2 Refereed review article in a scientific journal ) - Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis (2024)
- Lancet Infectious Diseases
(A2 Refereed review article in a scientific journal )



